WO2019223218A1 - Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast - Google Patents

Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast Download PDF

Info

Publication number
WO2019223218A1
WO2019223218A1 PCT/CN2018/109988 CN2018109988W WO2019223218A1 WO 2019223218 A1 WO2019223218 A1 WO 2019223218A1 CN 2018109988 W CN2018109988 W CN 2018109988W WO 2019223218 A1 WO2019223218 A1 WO 2019223218A1
Authority
WO
WIPO (PCT)
Prior art keywords
servings
chinese medicine
layer
traditional chinese
parts
Prior art date
Application number
PCT/CN2018/109988
Other languages
French (fr)
Chinese (zh)
Inventor
许汉珍
Original Assignee
Xu Hanzhen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xu Hanzhen filed Critical Xu Hanzhen
Publication of WO2019223218A1 publication Critical patent/WO2019223218A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • A61F7/03Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction
    • A61F7/032Compresses or poultices for effecting heating or cooling thermophore, i.e. self-heating, e.g. using a chemical reaction using oxygen from the air, e.g. pocket-stoves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/646Arachnids, e.g. spiders, scorpions, ticks or mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/648Myriapods, e.g. centipedes or millipedes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288Taraxacum (dandelion)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/51Gentianaceae (Gentian family)
    • A61K36/515Gentiana
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • A61N2/002Magnetotherapy in combination with another treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • A61N2/004Magnetotherapy specially adapted for a specific therapy
    • A61N2/008Magnetotherapy specially adapted for a specific therapy for pain treatment or analgesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00Magnetotherapy
    • A61N2/06Magnetotherapy using magnetic fields produced by permanent magnets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • A61F2007/0261Compresses or poultices for effecting heating or cooling medicated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Definitions

  • the invention belongs to the technical field of traditional Chinese medicine patches, and particularly relates to a traditional Chinese medicine transdermal drug delivery patch for promoting blood circulation and collaterals, which is clinically used to treat breast hyperplasia.
  • Breast hyperplasia is a breast disease that involves the proliferation of one or more tissues such as acinar epithelium, ductal epithelium, and fibrous connective tissue. It is a non-tumor, non-inflammatory breast epithelial proliferative disorder and belongs to the category of "breast" in Chinese medicine. . The age of onset is concentrated in 20 to 50 years old, and the incidence rate drops sharply after 50 years of age. Its incidence rate is about 40% of women of childbearing age and 75% of all breast diseases. It is the most common breast disease. It is generally believed that the lack of progesterone causes breast hyperplasia and incomplete restoration during the menstrual cycle, and the disease develops over time.
  • Traditional Chinese medicine treats this disease with a holistic concept, combining syndrome differentiation with disease differentiation, combining the whole with local treatment, combining internal and external treatment, combining long-term treatment with short-term treatment, and relieving liver qi, promoting blood circulation, dissipating blood stasis, and dissolving, From various aspects and angles, it plays the role of adjusting endocrine and treating both the symptoms and the symptoms.
  • the external treatment method of traditional Chinese medicine is aimed at the characteristics of patients with hyperplasia of mammary glands with local symptoms and signs. Using integrated external treatment can directly reach the clinic, which is one of the important ways to treat hyperplasia of mammary glands.
  • the transdermal preparation of traditional Chinese medicine of the present invention is a new type of multifunctional therapeutic patch integrating medicinal therapy, warming, magnetic therapy, and hyperthermia, which directly acts on breast lesions with its medicinal therapy, warming, magnetic therapy, and hyperthermia.
  • the part can stimulate local breast circulation by stimulating abundant breast blood vessels and meridians or acupoints, and it can clear the meridian, promote blood circulation, soften and loosen the knots, reduce symptoms, and alleviate the pain caused by lobular hyperplasia. , Has an adjuvant therapeutic effect on breast hyperplasia.
  • the purpose of the present invention is to provide a traditional Chinese medicine transdermal patch for promoting blood circulation, which can effectively improve the symptoms of breast pain, breast mass, nipple discharge and the like caused by hyperplasia of female breast. Because the drug has the function of promoting blood circulation and collaterals, it also has good curative effects on chronic diseases such as cervical spondylosis, waist and leg pain, chronic strain, spinal pain, rheumatoid arthritis, and osteoarthritis.
  • the present invention adopts the following technical solutions:
  • a traditional Chinese medicine transdermal patch for promoting blood circulation comprising an adhesive layer, an energy layer, a permanent magnet (magnetized layer), a drug film layer and a backing layer.
  • the energy layer is composed of an adhesive layer on its upper surface and The lower surface is covered with an air-impermeable film.
  • the inner side of the air-impermeable film is provided with a permanent magnet and a drug film layer, and the permanent magnet is located between the air-impermeable film and the drug film layer.
  • the lower surface of the drug film layer is also provided with a layer of release paper to cover the drug film layer and the adhesive layer.
  • the inner side of the air-impermeable film refers to the side close to the human skin
  • the outer side of the adhesive layer refers to the side far from the human skin.
  • the backing layer is made of a breathable non-woven fabric.
  • the energy layer contains a heat generating substance.
  • the air-impermeable film is made of an air-impermeable material, and the air-impermeable material includes air-impermeable plastic and air-impermeable cloth.
  • the medicine film layer is prepared by compounding a traditional Chinese medicine component and a polymer material.
  • a traditional Chinese medicine component is coated in a polymer material prepared by compounding polylactic acid and poly3-hydroxybutyrate, and is formulated into a drug film layer.
  • the traditional Chinese medicine components in the medicinal film layer are made of the following parts by weight of medicinal materials: 5-7 parts of deer grass, 6-10 parts of fleas, 3-5 parts of peach kernels, 2-4 parts of safflower, and 3-5 parts of frankincense.
  • the polymer materials are polylactic acid (PLA) and Poly 3-hydroxybutyrate (PHB).
  • the preparation method of the medicine film layer specifically includes the following steps:
  • step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 h to remove the solvent to obtain the drug film layer.
  • step 2) the mass ratio of PLA and PHB is (1 ⁇ 5): 5.
  • the ratio of the mass of the traditional Chinese medicine component to the total mass of PLA and PHB is 1: 9.
  • a traditional Chinese medicine component is coated in a polymer material made of a compound of polylactic acid and poly3-hydroxybutyrate.
  • the heating substance contained in the energy layer contacts oxygen and spontaneously generates heat to act on the film.
  • Layer which can make the drug release quickly, and because of the coating of the polymer material, the duration of the pharmacological effect is prolonged, maintaining a stable and durable blood drug concentration, while reducing the toxicity and side effects of the drug; on the breast, uterus or joints of the human body
  • the pain in the part can have a good therapeutic effect; and as the temperature of the energy layer increases, the volatilization and penetration of each medicinal ingredient in the drug film layer can be promoted, so as to further achieve a good blood circulation and relieve pain. effect;
  • a permanent magnet is added to a transdermal patch of traditional Chinese medicine.
  • it uses the penetrating effect of its magnetic lines of force to achieve the effects of recuperating and recuperating and regulating qi and blood.
  • the thermal magnetic field effect is enhanced, which can excite the medicinal ingredients such as volatile oil contained in the medicinal film layer and decompose them into smaller molecules, thereby helping to promote the transdermal absorption of the medicinal ingredients;
  • the traditional Chinese medicine transdermal patch of the present invention integrates medicinal therapy, warm moxibustion, hyperthermia, and magnetic therapy into one body, which can effectively improve the symptoms of breast pain, breast lumps, and nipple discharge caused by breast hyperplasia in women; Pain, chronic strain, spinal pain, rheumatoid arthritis, osteoarthritis and other chronic diseases also have very good effects.
  • FIG. 1 is a schematic structural diagram of a transdermal patch of Chinese medicine of the present invention; wherein, 1-adhesive layer, 2-energy layer (containing heat generating substance), 3-permanent magnet (magnetized layer), 4-medicine film layer, 5- Backing layer, 6-airtight film, 7-release paper;
  • FIG. 2 is a bottom view of FIG. 1 of the present invention.
  • the transdermal patch of Chinese medicine of the present invention includes an adhesive layer 1, an energy layer 2 (containing a heating substance), a permanent magnet (magnetized layer) 3, a drug film layer 4, and a backing layer 5. ;
  • the energy layer 2 is covered by an adhesive layer 1 on its upper surface and an air-impermeable film 6 on its lower surface.
  • a permanent magnet 3 and a drug film layer 4 are arranged inside the air-impermeable film 6, and the permanent magnet 3 It is located between the air-impermeable film 6 and the medicine film layer 2; a backing layer 5 is provided on the outside of the adhesive layer 1.
  • the backing layer 5 is made of a non-woven fabric.
  • the air-impermeable film 6 is made of an air-impermeable material, and the air-impermeable material includes air-impermeable plastic and air-impermeable cloth.
  • a release paper 7 is provided on the lower surface of the drug film layer 4 to cover the drug film layer 4 and the adhesive layer 1.
  • the drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
  • step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
  • the drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
  • PLA and PHB were dissolved with ethyl acetate (wherein the mass ratio of PLA and PHB was 1: 1), and each solution was prepared into a 10 wt% solution. The two solutions were mixed at room temperature to obtain a PLA / PHB blend. spare;
  • step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
  • the drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
  • step 3 Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)

Abstract

A traditional Chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast, comprising an adhesive layer, an energy layer, a magnetized layer, a medicinal film layer, and a backing layer. The backing layer is on the upper surface of the energy layer, and an air-impermeable film is on the lower surface of same. Below the air-impermeable film are, sequentially, a permanent magnet and the medicinal film layer. The outer side of the adhesive layer is the backing layer. The medicinal film layer is made from a composite of traditional Chinese medicine components and macromolecule material. The macromolecule material consists of a combination of PLA and PHB. The traditional Chinese medicine components are encapsulated within the macromolecule material. Heat produced by contact between a heat-emitting substance of the energy layer and oxygen acts on the medicinal layer, and is able to promote rapid release of traditional Chinese medicine active ingredients. The present patch is able to alleviate and dissipate pain and swelling caused by hyperplasia of the breast, while also being effective for treating cervical spondylosis, lower back and leg pain, chronic strain, spinal pain, rheumatic arthritis, osteoarthritis, and other chronic conditions.

Description

一种活血通络用于乳腺增生治疗的中药透皮贴剂Traditional Chinese medicine transdermal patch for treating breast hyperplasia by activating blood circulation 技术领域Technical field
本发明属于中药贴剂技术领域,具体涉及一种活血通络、临床上用于治疗乳腺增生的中药透皮给药贴剂。The invention belongs to the technical field of traditional Chinese medicine patches, and particularly relates to a traditional Chinese medicine transdermal drug delivery patch for promoting blood circulation and collaterals, which is clinically used to treat breast hyperplasia.
背景技术Background technique
乳腺增生病是以腺泡上皮、导管上皮及纤维结缔组织一种或多种组织增生为主要病理改变的乳房疾病,是非肿瘤、非炎症性的乳腺上皮增生性疾患,属于中医“乳癖”范畴。发病年龄集中于20~50岁,50岁以后发病率急骤下降。其发病率占育龄妇女的40%左右,占全部乳房病的75%,是最常见的乳房疾病。一般认为黄体素不足,使月经周期中乳腺增生和复旧不全,日久形成本病。 Breast hyperplasia is a breast disease that involves the proliferation of one or more tissues such as acinar epithelium, ductal epithelium, and fibrous connective tissue. It is a non-tumor, non-inflammatory breast epithelial proliferative disorder and belongs to the category of "breast" in Chinese medicine. . The age of onset is concentrated in 20 to 50 years old, and the incidence rate drops sharply after 50 years of age. Its incidence rate is about 40% of women of childbearing age and 75% of all breast diseases. It is the most common breast disease. It is generally believed that the lack of progesterone causes breast hyperplasia and incomplete restoration during the menstrual cycle, and the disease develops over time.
现代中医认为乳腺增生病的发生由肝郁气滞,或肝肾虚损,冲任失调,或痰凝血淤而成。中医治疗乳腺增生病,历史悠久,疗效确切且无明显毒副反应,复发率低。中医以整体观念对本病辨证论治,辨证与辨病相结合,整体与局部相结合,内治与外治相结合,长期治疗与短期治疗相结合,通过疏肝理气、活血化瘀、散结,从多方面、多角度起到调整内分泌,标本兼治的作用。尤其是中医外治法针对乳腺增生病患者以局部症状和体征为主的特点,采用集成外治治疗能直达病所,是治疗乳腺增生病的重要途径之一。Modern Chinese medicine believes that the occurrence of breast hyperplasia is caused by liver stagnation and qi stagnation, or liver and kidney deficiency, impaired imbalance, or sputum coagulation and stasis. Traditional Chinese medicine has a long history of treating breast hyperplasia, and its curative effect is definite, without obvious side effects, and the recurrence rate is low. Traditional Chinese medicine treats this disease with a holistic concept, combining syndrome differentiation with disease differentiation, combining the whole with local treatment, combining internal and external treatment, combining long-term treatment with short-term treatment, and relieving liver qi, promoting blood circulation, dissipating blood stasis, and dissolving, From various aspects and angles, it plays the role of adjusting endocrine and treating both the symptoms and the symptoms. In particular, the external treatment method of traditional Chinese medicine is aimed at the characteristics of patients with hyperplasia of mammary glands with local symptoms and signs. Using integrated external treatment can directly reach the clinic, which is one of the important ways to treat hyperplasia of mammary glands.
本发明的中药透皮给药制剂是集药疗、温炙、磁疗、热疗于一体的新型多功能治疗贴,以其药疗、温炙、磁疗、热疗等直接作用于乳腺病变部位,可通过对丰富的乳腺血管和经络或穴位的刺激,改善乳腺病变部位局部的微循环,起到疏通经络,活血化瘀、软坚散结作用,达到减轻症状,缓解乳腺小叶增生引起的疼痛,对乳腺增生病有辅助治疗作用。The transdermal preparation of traditional Chinese medicine of the present invention is a new type of multifunctional therapeutic patch integrating medicinal therapy, warming, magnetic therapy, and hyperthermia, which directly acts on breast lesions with its medicinal therapy, warming, magnetic therapy, and hyperthermia. The part can stimulate local breast circulation by stimulating abundant breast blood vessels and meridians or acupoints, and it can clear the meridian, promote blood circulation, soften and loosen the knots, reduce symptoms, and alleviate the pain caused by lobular hyperplasia. , Has an adjuvant therapeutic effect on breast hyperplasia.
技术问题technical problem
目前市面上用于乳腺增生的药剂贴中的药物成分,往往是将中药材直接粉碎后装包使用,这样有效成份不易释放,皮肤吸收甚微,药物的生物效价下降,而且药效损耗大,影响临床效果。因此,发明一种新型的活血通络的多功能中药制剂是非常必要的。At present, the medicinal ingredients in medicinal patches used for hyperplasia of the breast are often directly crushed and packaged for use. This way, the effective ingredients are not easy to release, the skin absorption is very small, the bioavailability of the drug is reduced, and the loss of the medicinal effect is large. , Affecting clinical results. Therefore, it is necessary to invent a new type of multifunctional traditional Chinese medicine preparation for activating blood circulation.
技术解决方案Technical solutions
本发明的目的在于提供一种活血通络的中药透皮贴剂,其能够有效改善女性乳腺增生引起的乳房疼痛、乳房肿块、乳头溢液等症状。由于该药物具有活血通络功能,对颈椎病、腰腿痛、慢性劳损、脊椎痛、风湿性关节炎、骨关节炎等慢性病也有很好的疗效。The purpose of the present invention is to provide a traditional Chinese medicine transdermal patch for promoting blood circulation, which can effectively improve the symptoms of breast pain, breast mass, nipple discharge and the like caused by hyperplasia of female breast. Because the drug has the function of promoting blood circulation and collaterals, it also has good curative effects on chronic diseases such as cervical spondylosis, waist and leg pain, chronic strain, spinal pain, rheumatoid arthritis, and osteoarthritis.
为实现上述目的,本发明采用如下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种活血通络的中药透皮贴剂,包括粘胶层、能量层、永磁体(磁化层)、药膜层及背衬层,所述能量层由位于其上表面的胶粘层和位于其下表面的不透气膜包覆,所述不透气膜的内侧设有永磁体和药膜层,永磁体位于不透气膜和药膜层之间;所述粘胶层的外侧设有背衬层;所述药膜层的下表面还设有一层离型纸覆盖在药膜层和粘胶层上。使用时,撕去药膜层下方的离型纸,将中药透皮制剂贴于患处,使药膜层直接与患处皮肤接触。上述的不透气膜的内侧是指靠近人体皮肤的一侧,粘胶层的外侧是指远离人体皮肤的一侧。A traditional Chinese medicine transdermal patch for promoting blood circulation, comprising an adhesive layer, an energy layer, a permanent magnet (magnetized layer), a drug film layer and a backing layer. The energy layer is composed of an adhesive layer on its upper surface and The lower surface is covered with an air-impermeable film. The inner side of the air-impermeable film is provided with a permanent magnet and a drug film layer, and the permanent magnet is located between the air-impermeable film and the drug film layer. The lower surface of the drug film layer is also provided with a layer of release paper to cover the drug film layer and the adhesive layer. When in use, peel off the release paper under the drug film layer and apply the traditional Chinese medicine transdermal preparation to the affected area so that the drug film layer directly contacts the skin of the affected area. The inner side of the air-impermeable film refers to the side close to the human skin, and the outer side of the adhesive layer refers to the side far from the human skin.
进一步的,所述背衬层采用透气的无纺布制成。Further, the backing layer is made of a breathable non-woven fabric.
进一步的,所述能量层内含发热物质。Further, the energy layer contains a heat generating substance.
进一步的,所述不透气膜由不透气材料制成,所述不透气材料包括不透气塑胶、不透气布料。Further, the air-impermeable film is made of an air-impermeable material, and the air-impermeable material includes air-impermeable plastic and air-impermeable cloth.
进一步的,所述药膜层由中药组分和高分子材料复合制得。本发明将中药组分包覆于由聚乳酸和聚3-羟基丁酸酯复合制得的高分子材料内,配制成药膜层。药膜层中的中药组分由以下重量份的药材原料制成:鹿衔草5~7份、 蚤休6~10份、桃仁3~5份、红花2~4份、乳香3~5份、没药3~5份、茜草3~5份、葵蓬菜8-10份、柴胡3~5份、枳壳2~4份、蒲公英4~8份、三棱3~5份、莪术3~5份、漏芦2~4份、山慈菇2~4份、大黄3~5份、干姜2~4份、蜈蜙3~5份、青皮1~3份、全蝎4~6份、水蛭4~6份、雪上一枝蒿1~3份、秦艽1~3份、阿魏2~4份和血竭4~8份;所述高分子材料为聚乳酸(PLA)和聚3-羟基丁酸酯(PHB)。Further, the medicine film layer is prepared by compounding a traditional Chinese medicine component and a polymer material. In the invention, a traditional Chinese medicine component is coated in a polymer material prepared by compounding polylactic acid and poly3-hydroxybutyrate, and is formulated into a drug film layer. The traditional Chinese medicine components in the medicinal film layer are made of the following parts by weight of medicinal materials: 5-7 parts of deer grass, 6-10 parts of fleas, 3-5 parts of peach kernels, 2-4 parts of safflower, and 3-5 parts of frankincense. Servings, 3 ~ 5 servings of myrrh, 3 ~ 5 servings of madder, 8-10 servings of sunflower, 3 ~ 5 servings of Bupleurum, 2 ~ 4 servings of coriander shells, 4 ~ 8 servings of dandelion, 3 ~ 5 servings of Sanling, 3 to 5 servings of curcuma, 2 to 4 servings of leaked reeds, 2 to 4 servings of mountain mushrooms, 3 to 5 servings of rhubarb, 2 to 4 servings of dried ginger, 3 to 5 servings of coriander, 1 to 3 servings of green peel, and 4 whole scorpions ~ 6 servings, 4 ~ 6 servings of leech, 1 ~ 3 servings of Artemisia annua on the snow, 1 ~ 3 servings of Qin Zhi, 2 ~ 4 servings of Awei and 4 ~ 8 servings of blood exhaustion; the polymer materials are polylactic acid (PLA) and Poly 3-hydroxybutyrate (PHB).
所述药膜层的制备方法具体包括以下步骤:The preparation method of the medicine film layer specifically includes the following steps:
1)按重量份数计,将鹿衔草5~7份、蚤休6~10份、桃仁3~5份、红花2~4份、乳香3~5份、没药3~5份、茜草3~5份、葵蓬菜8-10份、柴胡3~5份、枳壳2~4份、蒲公英4~8份、三棱3~5份、莪术3~5份、漏芦2~4份、山慈菇2~4份、大黄3~5份、干姜2~4份、蜈蜙3~5份、青皮1~3份、全蝎4~6份、水蛭4~6份、雪上一枝蒿1~3份、秦艽1~3份、阿魏2~4份和血竭4~8份粉碎后,加入其重量3-5倍85wt%的乙醇回流提取2次,每次1小时,合并两次提取液,过滤并回收乙醇;将所得提取液减压浓缩并干燥后,过80-100目筛,得到中药组分;1) Based on parts by weight, 5-7 parts of deer grass, 6-10 parts of fleas, 3-5 parts of peach kernels, 2-4 parts of safflower, 3-5 parts of frankincense, 3-5 parts of myrrh, 3 to 5 parts of madder, 8 to 10 parts of Kwai Peng, 3 to 5 parts of Bupleurum, 2 to 4 parts of coriander shell, 4 to 8 parts of dandelion, 3 to 5 parts of triangular ridge, 3 to 5 parts of turmeric, and 2 leaked reeds ~ 4 servings, Shanci mushrooms 2 ~ 4 servings, Rhubarb 3 ~ 5 servings, dried ginger 2 ~ 4 servings, crickets 3 ~ 5 servings, green peel 1 ~ 3 servings, whole scorpion 4 ~ 6 servings, and leech 4 ~ 6 servings 1 to 3 parts of Artemisia annua on the snow, 1 to 3 parts of Qin Wei, 2 to 4 parts of Awei, and 4 to 8 parts of blood exhaustion. After crushing, add 3-5 times the weight of 85% by weight of ethanol and reflux and extract 2 times, each time 1 For two hours, the two extracts were combined, filtered and ethanol recovered; the obtained extracts were concentrated under reduced pressure and dried, and then passed through an 80-100 mesh sieve to obtain a Chinese medicine component;
2)用乙酸乙酯分别溶解PLA和PHB,分别配制成8~10wt%的溶液,室温下将两种溶液混合,制得PLA/ PHB共混物,备用;2) Dissolve PLA and PHB with ethyl acetate, respectively, and prepare 8-10 wt% solutions. Mix the two solutions at room temperature to obtain PLA / PHB blend, ready for use;
3)取步骤1)制得的中药组分溶于乙醇中,得到中药液,将所得中药液加入到步骤2)制得的PLA/PHB共混物中,磁力搅拌6h,浇铸成膜,室温下真空干燥48h以除去溶剂,制得所述药膜层。3) Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 h to remove the solvent to obtain the drug film layer.
进一步的,步骤2)中,PLA和PHB的质量比为(1~5):5。Further, in step 2), the mass ratio of PLA and PHB is (1 ~ 5): 5.
进一步的,所述中药组分的质量与PLA和PHB总质量的比值为1:9。Further, the ratio of the mass of the traditional Chinese medicine component to the total mass of PLA and PHB is 1: 9.
有益效果Beneficial effect
(1)本发明将中药组分包覆于由聚乳酸和聚3-羟基丁酸酯复合制得的高分子材料内,能量层中含有的发热物质与氧气接触而自发产生热量作用于药膜层,能够使得药物快速释放,并且由于高分子材料的包覆,使得药效作用持续时间延长,维持稳定、持久的血药浓度,同时降低药物的毒性和副作用;对人体的乳房、子宫或关节部位的痛症能够起到很好的治疗效果;且随着能量层的温度提高,可促进药膜层中各药效成分的挥发、渗透,从而进一步达到良好的活血通络,行气止痛的效果;(1) In the present invention, a traditional Chinese medicine component is coated in a polymer material made of a compound of polylactic acid and poly3-hydroxybutyrate. The heating substance contained in the energy layer contacts oxygen and spontaneously generates heat to act on the film. Layer, which can make the drug release quickly, and because of the coating of the polymer material, the duration of the pharmacological effect is prolonged, maintaining a stable and durable blood drug concentration, while reducing the toxicity and side effects of the drug; on the breast, uterus or joints of the human body The pain in the part can have a good therapeutic effect; and as the temperature of the energy layer increases, the volatilization and penetration of each medicinal ingredient in the drug film layer can be promoted, so as to further achieve a good blood circulation and relieve pain. effect;
(2)本发明在中药透皮贴剂中加入永磁体,一方面是利用其磁力线的穿透作用,达到舒经活络、调理气血的效果,另一方面,磁石吸收能量层所释放的热量后,通过热磁场效应增强,能够激发药膜层中所含的挥发油等药效成分,使其分解成更小的分子,从而有助于促进药效成分的透皮吸收;(2) In the present invention, a permanent magnet is added to a transdermal patch of traditional Chinese medicine. On the one hand, it uses the penetrating effect of its magnetic lines of force to achieve the effects of recuperating and recuperating and regulating qi and blood. Later, the thermal magnetic field effect is enhanced, which can excite the medicinal ingredients such as volatile oil contained in the medicinal film layer and decompose them into smaller molecules, thereby helping to promote the transdermal absorption of the medicinal ingredients;
(3)本发明中药透皮贴剂集药疗、温灸、热疗、磁疗于一体,能够有效改善女性乳腺增生引起的乳房疼痛、乳房肿块、乳头溢液等症状;对颈椎病、腰腿痛、慢性劳损、脊椎痛、风湿性关节炎、骨关节炎等慢性病也有很好的疗效。(3) The traditional Chinese medicine transdermal patch of the present invention integrates medicinal therapy, warm moxibustion, hyperthermia, and magnetic therapy into one body, which can effectively improve the symptoms of breast pain, breast lumps, and nipple discharge caused by breast hyperplasia in women; Pain, chronic strain, spinal pain, rheumatoid arthritis, osteoarthritis and other chronic diseases also have very good effects.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为本发明中药透皮贴剂的结构示意图;其中,1-粘胶层,2-能量层(内含发热物质),3-永磁体(磁化层),4-药膜层,5-背衬层,6-不透气膜,7-离型纸;FIG. 1 is a schematic structural diagram of a transdermal patch of Chinese medicine of the present invention; wherein, 1-adhesive layer, 2-energy layer (containing heat generating substance), 3-permanent magnet (magnetized layer), 4-medicine film layer, 5- Backing layer, 6-airtight film, 7-release paper;
图2为本发明图1的仰视图。FIG. 2 is a bottom view of FIG. 1 of the present invention.
本发明的实施方式Embodiments of the invention
如图1、2所示,本发明的中药透皮贴剂,包括粘胶层1、能量层2(内含发热物质)、永磁体(磁化层)3、药膜层4和背衬层5;能量层2由位于其上表面的的粘胶层1和位于其下表面的不透气膜6包覆,不透气膜6的内侧设有永磁体3和药膜层4,所述永磁体3位于不透气膜6和药膜层2之间;所述粘胶层1的外侧设有背衬层5。As shown in FIGS. 1 and 2, the transdermal patch of Chinese medicine of the present invention includes an adhesive layer 1, an energy layer 2 (containing a heating substance), a permanent magnet (magnetized layer) 3, a drug film layer 4, and a backing layer 5. ; The energy layer 2 is covered by an adhesive layer 1 on its upper surface and an air-impermeable film 6 on its lower surface. A permanent magnet 3 and a drug film layer 4 are arranged inside the air-impermeable film 6, and the permanent magnet 3 It is located between the air-impermeable film 6 and the medicine film layer 2; a backing layer 5 is provided on the outside of the adhesive layer 1.
进一步的,所述背衬层5采用无纺布制成。Further, the backing layer 5 is made of a non-woven fabric.
进一步的,所述不透气膜6由不透气材料制成,所述不透气材料包括不透气塑胶、不透气布料。Further, the air-impermeable film 6 is made of an air-impermeable material, and the air-impermeable material includes air-impermeable plastic and air-impermeable cloth.
进一步的,所述药膜层4的下表面还设有一层离型纸7覆盖在药膜层4和粘胶层1上。Further, a release paper 7 is provided on the lower surface of the drug film layer 4 to cover the drug film layer 4 and the adhesive layer 1.
使用时,将该中药透皮贴剂从密封袋中取出,掀去覆盖在粘胶层及药物层上的离型纸,然后贴于乳房的疼痛部位或是关节患处。此时,空气通过背衬层进入能量层,引起发热物质发热,达到热疗的效果,并使药膜层和永磁体的温度提高,促进药物释放,以进一步达到药疗和磁疗的效果。When in use, remove the traditional Chinese medicine transdermal patch from the sealed bag, lift off the release paper covering the adhesive layer and the drug layer, and then apply it to the painful area of the breast or the joint affected area. At this time, the air enters the energy layer through the backing layer, causing the heating substance to generate heat, achieving the effect of thermal therapy, increasing the temperature of the drug film layer and the permanent magnet, and promoting the release of the drug to further achieve the effects of drug therapy and magnetic therapy.
为了使本发明所述的内容更加便于理解,下面结合具体实施方式对本发明所述的技术方案做进一步的说明,但是本发明不仅限于此。In order to make the content described in the present invention easier to understand, the technical solution described in the present invention is further described below in combination with specific embodiments, but the present invention is not limited thereto.
实施例Examples 11
中药透皮贴剂中的药物层由中药组分和高分子材料复合制得;所述药物层的制备方法具体包括以下步骤:The drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
1)按重量份数计,将鹿衔草5份、蚤休6份、桃仁3份、红花2份、乳香3份、没药3份、茜草3份、葵蓬菜8份、柴胡3份、枳壳2份、蒲公英4份、三棱3份、莪术3份、漏芦2份、山慈菇2份、大黄3份、干姜2份、蜈蜙3份、青皮1份、全蝎4份、水蛭4份、雪上一枝蒿1份、秦艽1份、阿魏2份和血竭4份粉碎后,加入其重量3倍85wt%的乙醇回流提取2次,每次1小时,合并两次提取液,过滤并回收乙醇;将所得提取液减压浓缩并干燥后,过80目筛,得到中药组分;1) In terms of parts by weight, 5 parts of deer grass, 6 parts of flea, 3 parts of peach kernel, 2 parts of safflower, 3 parts of frankincense, 3 parts of myrrh, 3 parts of madder, 8 parts of sunflower, and Bupleurum 3 servings, 2 servings of coriander shell, 4 servings of dandelion, 3 servings of Sanling, 3 servings of zedoary turmeric, 2 servings of leaked reed, 2 servings of mandarin mushroom, 3 servings of rhubarb, 2 servings of ginger, 3 servings of coriander, 1 serving of green peel, After smashing 4 parts of Scorpion, 4 parts of Leech, 1 part of Artemisia annua, 1 part of Qin Yuan, 2 parts of Fern and 4 parts of Blood Dried, add 3 times its weight of 85wt% ethanol to reflux for 2 times, each time for 1 hour. The two extracts were combined, filtered and ethanol recovered; the obtained extract was concentrated under reduced pressure and dried, and then passed through an 80-mesh sieve to obtain a Chinese medicine component;
2)用乙酸乙酯分别溶解PLA和PHB(其中PLA和PHB的质量比为1:5),分别配制成8wt%的溶液,室温下将两种溶液混合,制得PLA/ PHB共混物,备用;2) Dissolve PLA and PHB with ethyl acetate (wherein the mass ratio of PLA and PHB is 1: 5), prepare 8 wt% solutions, and mix the two solutions at room temperature to obtain PLA / PHB blends. spare;
3)取步骤1)制得的中药组分溶于乙醇中,得到中药液,将所得中药液加入到步骤2)制得的PLA/PHB共混物中,磁力搅拌6h,浇铸成膜,室温下真空干燥48h以除去溶剂,制得所述药物层;所述中药组分的质量与PLA和PHB总质量的比值为1:9。3) Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
实施例Examples 22
中药透皮贴剂中的药物层由中药组分和高分子材料复合制得;所述药物层的制备方法具体包括以下步骤:The drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
1)按重量份数计,将鹿衔草7份、蚤休10份、桃仁5份、红花4份、乳香5份、没药5份、茜草5份、葵蓬菜9份、柴胡5份、枳壳4份、蒲公英8份、三棱5份、莪术5份、漏芦4份、山慈菇4份、大黄5份、干姜4份、蜈蜙5份、青皮3份、全蝎6份、水蛭6份、雪上一枝蒿3份、秦艽3份、阿魏4份和血竭8份粉碎后,加入其重量5倍85wt%的乙醇回流提取2次,每次1小时,合并两次提取液,过滤并回收乙醇;将所得提取液减压浓缩并干燥后,过80目筛,得到中药组分;1) In terms of parts by weight, 7 parts of deer grass, 10 parts of flea, 5 parts of peach kernel, 4 parts of safflower, 5 parts of frankincense, 5 parts of myrrh, 5 parts of madder, 9 parts of sunflower, and Bupleurum 5 servings, 4 servings of coriander shell, 8 servings of dandelion, 5 servings of Sanling, 5 servings of zedoary rhizome, 4 servings of leaked reed, 4 servings of mandarin mushroom, 5 servings of rhubarb, 4 servings of dried ginger, 5 servings of coriander, 3 servings of green peel, After smashing 6 parts of scorpion, 6 parts of leech, 3 parts of Artemisia annua, 3 parts of Qin Zhi, 4 parts of Awei and 8 parts of blood exhaustion, add 5 times its weight and 85% by weight of ethanol to reflux and extract 2 times for 1 hour each time. The two extracts were combined, filtered and ethanol recovered; the obtained extract was concentrated under reduced pressure and dried, and then passed through an 80-mesh sieve to obtain a Chinese medicine component;
2)用乙酸乙酯分别溶解PLA和PHB(其中PLA和PHB的质量比为1:1),分别配制成10wt%的溶液,室温下将两种溶液混合,制得PLA/ PHB共混物,备用;2) PLA and PHB were dissolved with ethyl acetate (wherein the mass ratio of PLA and PHB was 1: 1), and each solution was prepared into a 10 wt% solution. The two solutions were mixed at room temperature to obtain a PLA / PHB blend. spare;
3)取步骤1)制得的中药组分溶于乙醇中,得到中药液,将所得中药液加入到步骤2)制得的PLA/PHB共混物中,磁力搅拌6h,浇铸成膜,室温下真空干燥48h以除去溶剂,制得所述药物层;所述中药组分的质量与PLA和PHB总质量的比值为1:9。3) Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
实施例Examples 33
中药透皮贴剂中的药物层由中药组分和高分子材料复合制得;所述药物层的制备方法具体包括以下步骤:The drug layer in the traditional Chinese medicine transdermal patch is prepared by compounding a traditional Chinese medicine component and a polymer material; the preparation method of the drug layer specifically includes the following steps:
1)按重量份数计,将鹿衔草6份、蚤休8份、桃仁4份、红花3份、乳香4份、没药4份、茜草4份、葵蓬菜10份、柴胡4份、枳壳3份、蒲公英6份、三棱4份、莪术4份、漏芦3份、山慈菇3份、大黄4份、干姜3份、蜈蜙4份、青皮2份、全蝎5份、水蛭5份、雪上一枝蒿2份、秦艽2份、阿魏3份和血竭6份粉碎后,加入其重量4倍85wt%的乙醇回流提取2次,每次1小时,合并两次提取液,过滤并回收乙醇;将所得提取液减压浓缩并干燥后,过100目筛,得到中药组分;1) In terms of parts by weight, 6 parts of deer grass, 8 parts of fleas, 4 parts of peach kernels, 3 parts of safflower, 4 parts of frankincense, 4 parts of myrrh, 4 parts of madder, 10 parts of sunflower, and Bupleurum 4 servings, 3 servings of coriander shell, 6 servings of dandelion, 4 servings of Sanling, 4 servings of zedoary turmeric, 3 servings of leaked reed, 3 servings of mandarin mushroom, 4 servings of rhubarb, 3 servings of dried ginger, 4 servings of coriander, 2 servings of green peel, After smashing 5 parts of whole scorpion, 5 parts of leech, 2 parts of Artemisia annua on the snow, 2 parts of Qin Zhi, 3 parts of Awei and 6 parts of blood exhaustion, add 4 times its weight and 85% by weight of ethanol to reflux and extract 2 times, each time for 1 hour. The two extracts were combined, filtered and ethanol recovered; the obtained extract was concentrated under reduced pressure and dried, and then passed through a 100-mesh sieve to obtain a Chinese medicine component;
2)用乙酸乙酯分别溶解PLA和PHB(其中PLA和PHB的质量比为3:5),分别配制成9wt%的溶液,室温下将两种溶液混合,制得PLA/ PHB共混物,备用;2) Dissolve PLA and PHB with ethyl acetate (wherein the mass ratio of PLA and PHB is 3: 5), and prepare 9 wt% solutions. Mix the two solutions at room temperature to obtain PLA / PHB blends. spare;
3)取步骤1)制得的中药组分溶于乙醇中,得到中药液,将所得中药液加入到步骤2)制得的PLA/PHB共混物中,磁力搅拌6h,浇铸成膜,室温下真空干燥48h以除去溶剂,制得所述药物层;所述中药组分的质量与PLA和PHB总质量的比值为1:9。3) Take the Chinese medicinal components obtained in step 1) and dissolve them in ethanol to obtain a Chinese medicinal solution. Add the obtained Chinese medicinal solution to the PLA / PHB blend prepared in step 2), magnetically stir for 6 h, and cast into a film. , And dried under vacuum at room temperature for 48 hours to remove the solvent to prepare the drug layer; the ratio of the mass of the Chinese medicine component to the total mass of PLA and PHB is 1: 9.
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。The above are only preferred embodiments of the present invention, and any equivalent changes and modifications made in accordance with the scope of patent application of the present invention shall fall within the scope of the present invention.

Claims (10)

  1. 一种活血通络的中药透皮贴剂,包括粘胶层、能量层、永磁体、药膜层及背衬层,其特征在于:所述能量层由位于其上表面的胶粘层和位于其下表面的不透气膜包覆,所述不透气膜的内侧设有永磁体和药膜层,所述永磁体位于不透气膜和药膜层之间;所述粘胶层的外侧设有背衬层;所述药膜层由中药组分和高分子材料复合制得。A traditional Chinese medicine transdermal patch for activating blood circulation includes a viscose layer, an energy layer, a permanent magnet, a medicine film layer and a backing layer, characterized in that the energy layer consists of an adhesive layer on its upper surface and an adhesive layer on its upper surface. The lower surface is covered with an air-impermeable film. A permanent magnet and a drug film layer are provided on the inner side of the air-impermeable film, and the permanent magnet is located between the air-impermeable film and the drug film layer. The outer side of the adhesive layer is provided. A backing layer; the medicine film layer is prepared by compounding a traditional Chinese medicine component and a polymer material.
  2. 根据权利要求1所述的中药透皮贴剂,其特征在于:药膜层中的中药组分由以下重量份的药材原料制成:鹿衔草5~7份、 蚤休6~10份、桃仁3~5份、红花2~4份、乳香3~5份、没药3~5份、茜草3~5份、葵蓬菜8-10份、柴胡3~5份、枳壳2~4份、蒲公英4~8份、三棱3~5份、莪术3~5份、漏芦2~4份、山慈菇2~4份、大黄3~5份、干姜2~4份、蜈蜙3~5份、青皮1~3份、全蝎4~6份、水蛭4~6份、雪上一枝蒿1~3份、秦艽1~3份、阿魏2~4份和血竭4~8份。The transdermal patch of traditional Chinese medicine according to claim 1, characterized in that the traditional Chinese medicine component in the medicinal film layer is made of the following parts by weight of medicinal materials: 5-7 parts of deer grass, 6-10 parts of fleas, 3 to 5 servings of peach kernels, 2 to 4 servings of safflower, 3 to 5 servings of frankincense, 3 to 5 servings of myrrh, 3 to 5 servings of madder, 8 to 10 servings of Kwai Peng, 3 to 5 servings of Bupleurum, and 2 shells ~ 4 servings, 4 ~ 8 servings of dandelion, 3 ~ 5 servings of triangular ridge, 3 ~ 5 servings of turmeric, 2 ~ 4 servings of leaked reeds, 2 ~ 4 servings of mountain mushroom, 3 ~ 5 servings of rhubarb, and 2 ~ 4 servings of dried ginger , 3 to 5 servings, 1 to 3 servings of green peel, 4 to 6 servings of whole scorpion, 4 to 6 servings of leech, 1 to 3 servings of Artemisia annua on the snow, 1 to 3 servings of Qin Wei, 2 to 4 servings of fern and blood exhaustion 4 ~ 8 servings.
  3. 根据权利要求2所述的中药透皮贴剂,其特征在于:所述药膜层中的中药组分的制备方法为:按重量份数计,将鹿衔草5~7份、蚤休6~10份、桃仁3~5份、红花2~4份、乳香3~5份、没药3~5份、茜草3~5份、葵蓬菜8-10份、柴胡3~5份、枳壳2~4份、蒲公英4~8份、三棱3~5份、莪术3~5份、漏芦2~4份、山慈菇2~4份、大黄3~5份、干姜2~4份、蜈蜙3~5份、青皮1~3份、全蝎4~6份、水蛭4~6份、雪上一枝蒿1~3份、秦艽1~3份、阿魏2~4份和血竭4~8份粉碎后,加入其重量3-5倍85wt%的乙醇回流提取2次,每次1小时,合并两次提取液,过滤并回收乙醇;将所得提取液减压浓缩并干燥后,过80-100目筛,得到中药组分。The transdermal patch of traditional Chinese medicine according to claim 2, characterized in that the preparation method of the traditional Chinese medicine component in the medicinal film layer is: by weight parts, 5-7 parts of deer's bite grass, and flea rest 6 ~ 10 servings, 3 ~ 5 servings of peach kernels, 2 ~ 4 servings of safflower, 3 ~ 5 servings of frankincense, 3 ~ 5 servings of myrrh, 3 ~ 5 servings of madder, 8-10 servings of sunflower seeds, 3 ~ 5 servings of bupleurum , 2 ~ 4 servings of coriander shells, 4 ~ 8 servings of dandelion, 3 ~ 5 servings of triangular ridges, 3 ~ 5 servings of turmeric, 2 ~ 4 servings of leaked reeds, 2 ~ 4 servings of mountain mushroom, 3 ~ 5 servings of rhubarb, dried ginger 2 to 4 servings, 3 to 5 servings, 1 to 3 servings of green peel, 4 to 6 servings of scorpion, 4 to 6 servings of leech, 1 to 3 servings of Artemisia annua on the snow, 1 to 3 servings of Qin Wei, 2 to 4 servings of Wei After crushing 4 to 8 parts of blood and 8 parts of blood, add 3-5 times its weight of 85% by weight of ethanol to reflux and extract twice for 1 hour each time. Combine the two extracts, filter and recover the ethanol; concentrate the resulting extract under reduced pressure. After drying, it is sieved through an 80-100 mesh sieve to obtain the traditional Chinese medicine component.
  4. 根据权利要求1所述的中药透皮贴剂,其特征在于:所述高分子材料为聚乳酸和聚3-羟基丁酸酯。The transdermal patch of traditional Chinese medicine according to claim 1, wherein the polymer material is polylactic acid and poly3-hydroxybutyrate.
  5. 根据权利要求1所述的中药透皮贴剂,其特征在于:所述药膜层的制备方法具体包括以下步骤:The transdermal patch of Chinese medicine according to claim 1, wherein the method for preparing the medicinal film layer comprises the following steps:
    1)用乙酸乙酯分别溶解聚乳酸和聚3-羟基丁酸酯,分别配制成8~10wt%的溶液,室温下将两种溶液混合,制得聚乳酸/聚3-羟基丁酸酯共混物,备用;1) Dissolve polylactic acid and poly3-hydroxybutyrate separately with ethyl acetate to prepare 8-10 wt% solutions, and mix the two solutions at room temperature to obtain a polylactic acid / poly-3-hydroxybutyrate co-polymer. Mixture
    2)取中药组分溶于乙醇中,得到中药液,将所得中药液加入到步骤1)制得的聚乳酸/聚3-羟基丁酸酯共混物中,磁力搅拌6h,浇铸成膜,室温下真空干燥48h以除去溶剂,制得所述药膜层。2) Dissolve the Chinese medicinal components in ethanol to obtain a Chinese medicinal solution, and add the obtained Chinese medicinal solution to the polylactic acid / poly 3-hydroxybutyrate blend prepared in step 1), magnetically stir for 6 hours, and cast into The film was dried under vacuum at room temperature for 48 h to remove the solvent, and the drug film layer was prepared.
  6. 根据权利要求5所述的中药透皮贴剂,其特征在于:步骤1)中,聚乳酸和聚3-羟基丁酸酯的质量比为(1~5):5。The transdermal patch of Chinese medicine according to claim 5, characterized in that in step 1), the mass ratio of polylactic acid and poly3-hydroxybutyrate is (1 ~ 5): 5.
  7. 根据权利要求5所述的中药透皮贴剂,其特征在于:所述中药组分的质量与聚乳酸和聚3-羟基丁酸酯总质量的比值为1:9。The transdermal patch of Chinese medicine according to claim 5, characterized in that the ratio of the mass of the Chinese medicine component to the total mass of polylactic acid and poly3-hydroxybutyrate is 1: 9.
  8. 根据权利要求1所述的中药透皮贴剂,其特征在于:所述背衬层采用透气的无纺布制成。The transdermal patch of traditional Chinese medicine according to claim 1, wherein the backing layer is made of a breathable non-woven fabric.
  9. 根据权利要求1所述的中药透皮贴剂,其特征在于:所述能量层内含发热物质。The transdermal patch of Chinese medicine according to claim 1, wherein the energy layer contains a heating substance.
  10. 根据权利要求1所述的中药透皮贴剂,其特征在于:所述药膜层的下表面还设有一层离型纸覆盖在药膜层和粘胶层上。The transdermal patch of traditional Chinese medicine according to claim 1, characterized in that: the lower surface of the medicinal film layer is further provided with a layer of release paper to cover the medicinal film layer and the adhesive layer.
PCT/CN2018/109988 2018-05-24 2018-10-12 Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast WO2019223218A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810508504.2A CN108404095A (en) 2018-05-24 2018-05-24 A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia
CN201810508504.2 2018-05-24

Publications (1)

Publication Number Publication Date
WO2019223218A1 true WO2019223218A1 (en) 2019-11-28

Family

ID=63140450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/109988 WO2019223218A1 (en) 2018-05-24 2018-10-12 Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast

Country Status (2)

Country Link
CN (1) CN108404095A (en)
WO (1) WO2019223218A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108404095A (en) * 2018-05-24 2018-08-17 福州鑫美源生物医药工程有限公司 A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia
CN110326827A (en) * 2019-08-06 2019-10-15 江苏万鸿健康科技有限公司 A kind of health care chest pad for preventing and treating the proliferation of mammary gland

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204133878U (en) * 2014-10-07 2015-02-04 胡海帆 Be used for the treatment of the medical ointment plaster of hysteromyoma and chronic pelvic inflammatory disease
CN205360237U (en) * 2016-02-06 2016-07-06 绍兴易邦医用品有限公司 Dressing
CN107648530A (en) * 2017-11-02 2018-02-02 青海喜玛拉雅药业有限公司 Pain relieving plaster
CN108404095A (en) * 2018-05-24 2018-08-17 福州鑫美源生物医药工程有限公司 A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102335369A (en) * 2010-07-22 2012-02-01 潘立芝 Traditional Chinese medicinal adhesive plaster for treating mammary gland hyperplasia
CN102552818A (en) * 2012-02-15 2012-07-11 李新民 External pharmaceutical composition for treating mammary gland diseases and preparation method thereof
CN104826016B (en) * 2015-05-14 2019-01-29 成都市康飞药业有限公司 A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland
CN107617083A (en) * 2017-09-14 2018-01-23 王风连 Treat the patch of the proliferation of mammary gland

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN204133878U (en) * 2014-10-07 2015-02-04 胡海帆 Be used for the treatment of the medical ointment plaster of hysteromyoma and chronic pelvic inflammatory disease
CN205360237U (en) * 2016-02-06 2016-07-06 绍兴易邦医用品有限公司 Dressing
CN107648530A (en) * 2017-11-02 2018-02-02 青海喜玛拉雅药业有限公司 Pain relieving plaster
CN108404095A (en) * 2018-05-24 2018-08-17 福州鑫美源生物医药工程有限公司 A kind of Chinese medicine transdermal patch promoting blood circulation and removing obstruction in channels for curing mammary gland hyperplasia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WANG, CHUNHUI, ET. AL.: "Analysis of the Prescription Composition Law of TCM External Therapy for the Treatment of Hyperplasia of Mammary Glands", HENAN TRADITIONAL CHINESE MEDICINE, vol. 37, no. 11, pages 2041 - 2044 *

Also Published As

Publication number Publication date
CN108404095A (en) 2018-08-17

Similar Documents

Publication Publication Date Title
CN110420311A (en) A kind of asthma moxibustion and preparation method thereof
WO2017129132A1 (en) Healthcare hot compress chinese medicine bag and preparation method for same
WO2019223218A1 (en) Traditional chinese medicine transdermal patch for promoting blood circulation and clearing meridians to treat hyperplasia of the breast
CN107998349A (en) A kind of external application mud moxibustion and preparation method thereof
CN106620622A (en) Moxibustion composition and preparation method and application thereof
CN107617083A (en) Treat the patch of the proliferation of mammary gland
CN104888139A (en) Production method of traditional Chinese medicine moxa stick with effect of breast stagnant blood eliminating
CN106963923A (en) A kind of Chinese medicine composition and preparation method and application with analgesic activity
CN104546983B (en) A kind of primary and secondary emplastrum for treating rheumatism and preparation method
CN1132616C (en) Traditional Chinese medicine for treating arthralgia-syndrome
CN109010413A (en) It is a kind of for female breast lump, breast pain, mazoitis emplastrum
CN102078593B (en) Application of toad peptide antibiotic for preparing medicines for curing diabetic foot
CN102423364A (en) Straightening plaster for treating facial paralysis and preparation method thereof
CN111658716A (en) Hydrogel magnetic therapy traditional Chinese medicine plaster and preparation method thereof
CN106109572A (en) One treats osteoporotic Chinese medicine composition and preparation method thereof
CN106139099A (en) Chinese medicinal ointment for the treatment of neck-shoulder pain, lumbago and leg pain and preparation method thereof
CN101518579B (en) Pressure stabilizing deoppilant and preparation process
CN101628063A (en) Externally-applied plaster for treating synovitis
CN105125798A (en) Plaster and preparation method thereof
CN110755578A (en) External traditional Chinese medicine for treating plantar wart and preparation method thereof
CN108514573A (en) A kind of topical Chinese medicine plaster and Chinese medicine lotion for external use drug paste
CN103961618A (en) Plaster for treating pains caused by wind-cold damp pathogens
CN109432060A (en) A kind of moxibustion patch and preparation method thereof for treating cough due to wind-cold evil
CN115040574B (en) Traditional Chinese medicine composition and traditional Chinese medicine preparation for treating thyroid nodule and preparation method thereof
CN106955314A (en) Heat-clearing river Huang of invigorating blood circulation dissipates

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18920057

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18920057

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 18920057

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 18920057

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 04/03/2022)

122 Ep: pct application non-entry in european phase

Ref document number: 18920057

Country of ref document: EP

Kind code of ref document: A1